West African Emerging Infectious Disease Research Center (WA-EIDRC)
West African Emerging Infectious Disease Research Center (WA-EIDRC)
批准号:
10910587
负责人:
Kristian Graugaard Andersen
金额:
$23.6万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-21 至 2025-04-30
关键词:
AccelerationAcuteAffectAfricaAfricanAnimalsAreaAwarenessBiological AssayChiropteraClinicalClinical ManagementClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicable DiseasesCommunicationCommunitiesCountryDecentralizationDetectionDevelopmentDiagnosticDiagnostic testsDisease OutbreaksEbolaEducational workshopEmerging Communicable DiseasesEnsureEpidemicEpidemiologistEvolutionFoundationsFrequenciesFundingFutureGenomicsGoalsHealthHumanImmune responseInfectionInfectious Diseases ResearchInfrastructureKnowledgeLassa virusLiberiaMetagenomicsMethodsMolecular EpidemiologyNational Institute of Allergy and Infectious DiseaseNatural HistoryNigeriaOutcomePathogenesisPatientsPersonsPrevalencePrevention strategyProtocols documentationPublic HealthRNARNA VirusesRapid diagnosticsReactionReagentResearchResearch PersonnelRiskRisk FactorsRodentSecuritySenegalSierra LeoneStandardizationSurveysSystemTechnology TransferTestingTrainingUnited StatesUnited States National Institutes of HealthViral Hemorrhagic FeversVirusVirus DiseasesWorkWorld BankZIKAcohortcomputerized toolsdata sharingdiagnostic assaydiagnostic criteriadiagnostic technologiesdiagnostic toolemerging pathogenexperienceflexibilityfuture outbreakfuture pandemicgenome sequencingimprovedmetagenomic sequencingmicrobialnew outbreaknew technologynovelpandemic potentialpandemic preparednesspathogenpathogenic viruspreventpriority pathogenpublic health emergencypublic health interventionpublic health relevanceresponsetechnology developmenttooltransmission processviral transmission
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Ensuring a world safe from microbial threats is a pressing challenge, as outbreaks exact tolls on human health, disrupt regional security, and have the potential to rapidly escalate into global crises. In recent years, severe outbreaks of Ebola, Lassa, Zika, and other emerging viruses have illustrated how vulnerable the world is to threats from RNA viral pathogens. These public health emergencies have exposed the urgent need for improved infrastructure, scientific knowledge, and diagnostic tools in areas of the world most at risk, and underscore the need for proactive pathogen surveillance, detection, and discovery. West Africa has a disproportionate vulnerability to outbreaks, but we lack awareness of acute threats, their natural history, and effective strategies for prevention. Rooted research between local and global partners, combined with novel assays and strategies for pandemic preparedness is required to answer these questions. We will build the capacity to rapidly respond to future outbreaks by establishing the West African Research Network for Infectious Diseases. This network will expand on years of successful cross-disciplinary research and capacity building, bringing together leading researchers from the United States, Liberia, Nigeria, Senegal, and Sierra Leone. We will: (1) perform comprehensive surveys of acute RNA viral disease and determine critical threats circulating in hosts and reservoirs; (2) identify risk factors of virus transmission and evolution; (3) dissect pathogenesis and natural history of severe RNA viral diseases; and (4) determine diagnostic criteria for infection outcome to guide public health interventions. Our work will significantly expand research capacity in West Africa via technology development of novel solutions for surveillance, diagnostics, and pathogen discovery. By establishing our network with a focus on priority pathogen research, technology transfer, training, and capacity building, we will develop flexible strategies for detecting, mitigating, and preventing the emergence of future infectious disease outbreaks.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2.
基于SARS-COV-2的基于SARS-COV-2的基于SARS-COV-2的基于简化的灭活,扩增和CAS13的检测。
DOI:
10.1038/s41467-020-19097-x
发表时间:
2020-11-20
期刊:
Nature communications
影响因子:
16.6
作者:
[Arizti-Sanz J, Freije CA, Stanton AC, Petros BA, Boehm CK, Siddiqui S, Shaw BM, Adams G, Kosoko-Thoroddsen TF, Kemball ME, Uwanibe JN, Ajogbasile FV, Eromon PE, Gross R, Wronka L, Caviness K, Hensley LE, Bergman NH, MacInnis BL, Happi CT, Lemieux JE, Sabeti PC, Myhrvold C]
通讯作者:
Myhrvold C
DOI:
10.3390/microorganisms9030586
发表时间:
2021-03-12
期刊:
Microorganisms
影响因子:
4.5
作者:
[Shaffer JG, Schieffelin JS, Momoh M, Goba A, Kanneh L, Alhasan F, Gbakie M, Engel EJ, Bond NG, Hartnett JN, Nelson DKS, Bush DJ, Boisen ML, Heinrich ML, Rowland MM, Branco LM, Samuels RJ, Garry RF, Grant DS, The Viral Hemorrhagic Fever Consortium]
通讯作者:
The Viral Hemorrhagic Fever Consortium
DOI:
10.1038/s41598-021-91961-2
发表时间:
2021-07-01
期刊:
Scientific reports
影响因子:
4.6
作者:
[Happi AN, Ogunsanya OA, Oguzie JU, Oluniyi PE, Olono AS, Heeney JL, Happi CT]
通讯作者:
Happi CT
DOI:
10.7717/peerj.12129
发表时间:
2021
期刊:
PeerJ
影响因子:
2.7
作者:
[Oluniyi PE, Ajogbasile F, Oguzie J, Uwanibe J, Kayode A, Happi A, Ugwu A, Olumade T, Ogunsanya O, Eromon PE, Folarin O, Frost SDW, Heeney J, Happi CT]
通讯作者:
Happi CT
DOI:
10.1080/22221751.2024.2307511
发表时间:
2024-12
期刊:
Emerging microbes & infections
影响因子:
13.2
作者:
[]
通讯作者:
共 13 条
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10653441
-
项目类别:
-
资助金额:$184.89万
-
财政年份:2022
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology (CViSB)
-
批准号:10469781
-
项目类别:
-
资助金额:$59.71万
-
财政年份:2021
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology Administrative Core
-
批准号:10469782
-
项目类别:
-
资助金额:$59.71万
-
财政年份:2021
-
负责人:Kristian Graugaard Andersen
-
依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10440593
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2021
-
负责人:Kristian Graugaard Andersen
-
依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10631738
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2020
-
负责人:Kristian Graugaard Andersen
-
依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10394323
-
项目类别:
-
资助金额:$174.99万
-
财政年份:2020
-
负责人:Kristian Graugaard Andersen
-
依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10842168
-
项目类别:
-
资助金额:$80.18万
-
财政年份:2020
-
负责人:Kristian Graugaard Andersen
-
依托单位:
West African Emerging Infectious Disease Research Center (WA-EIDRC)
-
批准号:10616665
-
项目类别:
-
资助金额:$174.13万
-
财政年份:2020
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology Administrative Core
-
批准号:10579082
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology (CViSB)
-
批准号:10248803
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Systems biology of Ebola virus and Lassa virus determinants of infection outcome
-
批准号:10310606
-
项目类别:
-
资助金额:$11.52万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology Administrative Core
-
批准号:10310601
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Project 2
-
批准号:10558424
-
项目类别:
-
资助金额:$64.26万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology (CViSB)
-
批准号:10579081
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology (CViSB)
-
批准号:10374714
-
项目类别:
-
资助金额:$255.0万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Administrative Core
-
批准号:10558419
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Consortium for Viral Systems Biology (CViSB)
-
批准号:10356250
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Systems biology of Ebola virus and Lassa virus determinants of infection outcome
-
批准号:10374720
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Systems biology of Ebola virus and Lassa virus determinants of infection outcome
-
批准号:10579087
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
Center for Viral Systems Biology (CViSB)
-
批准号:10558418
-
项目类别:
-
资助金额:$265.04万
-
财政年份:2018
-
负责人:Kristian Graugaard Andersen
-
依托单位:
海外基金